These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 37394531

  • 1. Clinical features analysis of Kawasaki disease with abdominal symptoms as the first manifestation.
    Yang P, Mao Z, Sun M, Guo J.
    Eur J Pediatr; 2023 Sep; 182(9):4049-4057. PubMed ID: 37394531
    [Abstract] [Full Text] [Related]

  • 2. [Clinical analysis of 942 cases of Kawasaki disease].
    Zhang W, Li Q, Zhao XD, Tang XM, Wang XG, Wang M, Wu DQ, Ou Q, Yang XQ.
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):324-8. PubMed ID: 16780705
    [Abstract] [Full Text] [Related]

  • 3. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
    Qiu Y, Wu J, Fang XY, Lin Z, Wu BY, Cai RY, Xu XY, Zheng H.
    Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
    [Abstract] [Full Text] [Related]

  • 4. Intravenous immunoglobulin for the treatment of Kawasaki disease.
    Broderick C, Kobayashi S, Suto M, Ito S, Kobayashi T.
    Cochrane Database Syst Rev; 2023 Jan 25; 1(1):CD014884. PubMed ID: 36695415
    [Abstract] [Full Text] [Related]

  • 5. Analysis of Age, Sex, Lack of Response to Intravenous Immunoglobulin, and Development of Coronary Artery Abnormalities in Children With Kawasaki Disease in Japan.
    Takekoshi N, Kitano N, Takeuchi T, Suenaga T, Kakimoto N, Suzuki T, Kada TT, Shibuta S, Tachibana S, Murayama Y, Yamaga H, Suzuki H.
    JAMA Netw Open; 2022 Jun 01; 5(6):e2216642. PubMed ID: 35696166
    [Abstract] [Full Text] [Related]

  • 6. Correlation between the Level of Inflammatory Cytokines and Prognosis in Children with IVIG-sensitive Kawasaki Disease and IVIG-resistant Kawasaki Disease.
    Zhang H, Song HB, Wang DX, Deng HY, Sun WL.
    Pak J Med Sci; 2022 Jun 01; 38(5):1165-1169. PubMed ID: 35799766
    [Abstract] [Full Text] [Related]

  • 7. Kawasaki disease in Sicily: clinical description and markers of disease severity.
    Maggio MC, Corsello G, Prinzi E, Cimaz R.
    Ital J Pediatr; 2016 Nov 02; 42(1):92. PubMed ID: 27806720
    [Abstract] [Full Text] [Related]

  • 8. Gastrointestinal presentation of Kawasaki disease: A red flag for severe disease?
    Fabi M, Corinaldesi E, Pierantoni L, Mazzoni E, Landini C, Bigucci B, Ancora G, Malaigia L, Bodnar T, Di Fazzio G, Lami F, Valletta E, Cicero C, Biasucci G, Iughetti L, Marchetti F, Sogno Valin P, Amarri S, Brusa S, Sprocati M, Maggiore G, Dormi A, Lanzoni P, Donti A, Lanari M.
    PLoS One; 2018 Nov 02; 13(9):e0202658. PubMed ID: 30180185
    [Abstract] [Full Text] [Related]

  • 9. Reevaluation of the efficacy of intravenous gammaglobulin in the prevention and treatment of coronary artery lesion in Kawasaki disease.
    Qin L, Saumu MT, Wang H, Shi H, Hu X, Cheng P.
    J Huazhong Univ Sci Technolog Med Sci; 2005 Nov 02; 25(3):348-50, 370. PubMed ID: 16201293
    [Abstract] [Full Text] [Related]

  • 10. Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials.
    Lei WT, Chang LS, Zeng BY, Tu YK, Uehara R, Matsuoka YJ, Su KP, Lee PC, Cavalcante JL, Stubbs B, Lin PY, Wu YC, Hsu CW, Chen TY, Chen YW, Yeh PY, Sun CK, Tseng PT, Kao YH.
    EBioMedicine; 2022 Apr 02; 78():103946. PubMed ID: 35306339
    [Abstract] [Full Text] [Related]

  • 11. Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study.
    Zhang X, He Y, Shao Y, Hang B, Xu Z, Chu M.
    Pediatr Rheumatol Online J; 2021 Jun 26; 19(1):96. PubMed ID: 34174872
    [Abstract] [Full Text] [Related]

  • 12. Non-coronary cardiac events, younger age, and IVIG unresponsiveness increase the risk for coronary aneurysms in Italian children with Kawasaki disease.
    Fabi M, Andreozzi L, Frabboni I, Dormi A, Corinaldesi E, Lami F, Cicero C, Tchana B, Francavilla R, Sprocati M, Bigucci B, Balsamo C, Valin PS, Di Fazzio G, Iughetti L, Valletta E, Marchetti F, Donti A, Lanari M.
    Clin Rheumatol; 2021 Apr 26; 40(4):1507-1514. PubMed ID: 32936425
    [Abstract] [Full Text] [Related]

  • 13. Risk factors and derived formosa score for intravenous immunoglobulin unresponsiveness in Taiwanese children with Kawasaki disease.
    Lin MT, Chang CH, Sun LC, Liu HM, Chang HW, Chen CA, Chiu SN, Lu CW, Chang LY, Wang JK, Wu MH.
    J Formos Med Assoc; 2016 May 26; 115(5):350-5. PubMed ID: 25910931
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for coronary artery lesions in children with Kawasaki disease.
    Duan J, Jiang H, Lu M.
    Arch Argent Pediatr; 2020 Oct 26; 118(5):327-331. PubMed ID: 32924395
    [Abstract] [Full Text] [Related]

  • 15. Factors Predicting Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Lesion in Patients with Kawasaki Disease: Analysis of the Korean Nationwide Multicenter Survey from 2012 to 2014.
    Kim MK, Song MS, Kim GB.
    Korean Circ J; 2018 Jan 26; 48(1):71-79. PubMed ID: 29171205
    [Abstract] [Full Text] [Related]

  • 16. [Association of liver damage with coronary artery lesion and no response to intravenous immunoglobulin in the acute stage of Kawasaki disease].
    Hu HM, Chen XZ, Zhang YL, DU ZD.
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jun 15; 24(6):681-686. PubMed ID: 35762436
    [Abstract] [Full Text] [Related]

  • 17. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
    Qin LJ, Wang HW, Hu XF, Liu QJ, Shi H, Wei YX, Chen QJ, Cheng PX.
    Zhonghua Er Ke Za Zhi; 2006 Dec 15; 44(12):891-5. PubMed ID: 17254453
    [Abstract] [Full Text] [Related]

  • 18. C-Reactive Protein to Albumin Ratio for Predicting Coronary Artery Lesions and Intravenous Immunoglobulin Resistance in Kawasaki Disease.
    Tsai CM, Yu HR, Tang KS, Huang YH, Kuo HC.
    Front Pediatr; 2020 Dec 15; 8():607631. PubMed ID: 33324592
    [Abstract] [Full Text] [Related]

  • 19. EFFICACY OF INTRAVENOUS IMMUNOGLOBULIN ALONE ON CORONARY ARTERY LESION REDUCTION IN KAWASAKI DISEASE.
    Kuo HC, Lin MC, Kao CC, Weng KP, Ding Y, Chen CJ, Jan SL, Chien KJ, Ko CH, Lin CY, Lei WT, Chang LS, Guo MM, Yang KD, Sylvester KG, Han Z, Whitin JC, Tian L, Chubb H, Ceresnak SR, McElhinney D, Cohen HJ, Ling XB.
    medRxiv; 2024 Jul 12. PubMed ID: 39040184
    [Abstract] [Full Text] [Related]

  • 20. [Association between duration of fever before treatment and intravenous immunoglobulin resistance in Kawasaki disease].
    Wang X, Pan SL, DU ZH, Ji ZX, Luo G, Sun HX, Ma SJ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Apr 15; 24(4):399-404. PubMed ID: 35527415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.